Nymox Pharmaceutical Corporation (NYMX) Declined -6.81% or -0.16 To Price $2.19 On Monday


Nymox Pharmaceutical Corporation (NYMX) declined -6.81% or -0.16 to $2.19. It is near 79213 shares traded, which is 86.14% compare to the average total volume 91954. The market cap of NYMX is $139.54 million. The year to date change is 42.87%. The 52 week price range is from $1.25 to $4.6. Price of NYMX have changed 8.55% during last week. It have changed 10.85% over last month, 64.34% over last 3 months, -7.84% over last 6 months and -41.54% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NYMX is 2.18. It is -0.46% below current price. The stock is at support level of 50-day moving averages. The 200-day Moving Averages for NYMX is 2.43. It is 10.96% above current price. The 52-week High is 4.6. It is 110.05% from the current price. The 52-week Low is 1.25. It is -42.92% from current price.

There are some statistics of NYMX. It is has market cap $139.54 million. The share outstanding is 63.72 million. The average volume is 91954. The percent of top 15 Institution holding is 10.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NYMX is -568.78%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NYMX is -340.42%.


Tags:

Share this post